The Trump administration has reportedly attempted to convince a German-based pharmaceutical company to bring its coronavirus research to the US — and to make its potential vaccine available exclusively to Americans.
According to reporting from Reuters’s Paul Carrel and Andreas Rinke, President Donald Trump reportedly offered “large sums of money” to CureVac, a biopharmaceutical company based in the southwest Germany city of Tübingen, to relocate their coronavirus vaccine research to the United States. And according to the German newspaper Welt am Sonntag, Trump wanted the vaccine to be “only for the United States.”
A spokesperson for the German Health Ministry confirmed Welt’s reporting to Reuters, but in a statement on Sunday, the company pushed back against any speculation of a takeover.
“Internal efforts are focused on the development of a coronavirus vaccine with the goal to reach, help and to protect people and patients worldwide,” a statement from CureVac read. The company “rejects allegations about offers for acquisition of the company or its technology.”
According to Reuters, German lawmakers reportedly made counteroffers to convince the company to remain. And a spokesperson for the German Economy Ministry told Reuters that attempts by other countries to poach German companies could lead to Berlin invoking a law allowing it to review takeover attempts by non-EU countries “if national or European security interests are at stake.”
The US has said such a measure won’t be necessary — a Trump administration official also pushed back against notions that the White House has attempted to poach the vaccine.
“This story is wildly overplayed,” the official told Reuters. “The US government has spoken with many companies that claim they can help with a vaccine. Most of these companies already received seed funding from US investors.”
The official added that “any solution found would be shared with the world.”
Trump has promised a vaccine will be available “soon” — but that’s unlikely
As Katelyn Burns has explained for Vox, Trump has pushed aggressively for a vaccine for weeks — and has promised to deliver one in a time frame that isn’t realistic:
In general, even the timeline Fauci outlined is ambitious: Typically, vaccines take two to five years to develop; however, the World Health Organization (WHO) has said that, because of global urgency, it is reasonable to expect a vaccine in 18 months.
Although Trump has been told this by pharmaceutical executives, he has continued to promise both a vaccine and a treatment will be available soon.
“We had a great meeting today with a lot of the great companies, and they’re going to have vaccines, I think, relatively soon,” he said at a campaign rally in Charlotte, North Carolina, on March 2. “And they’re going to have something that makes you better, and that’s going to actually take place we think even sooner.”
CureVac reportedly has vaccine candidates that it believes could be ready for clinical trials in humans by June or July. But as Burns wrote, a vaccine won’t prevent the current spread — and researchers still have many hurdles to overcome before a vaccine will become available. As Vox’s Julia Belluz, Umair Irfan, and Brian Resnick have written: